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Neurological syndromes are the most frequent clinical presentations of 
mitochondrial disorders, a group of human diseases characterized by defects 
of the mitochondrial energy output. Mitochondrial diseases are caused both 
by mutations, acquired or inherited, within mitochondrial DNA (mtDNA) and 
genetic inheritance. To date, more than 200 disease-causing point mutations to 
the mitochondrial genome have been reported. 
Pearson syndrome 
The disease typically begins in infancy or early childhood. It is characterized 
by refractory sideroblastic anemia, vacuolization of bone marrow precursors 
and exocrine pancreatic dysfunction. Both sexes are affected. Hematological 
signs begin in infancy, although a few neonatal cases have been described. 
These signs include macrocytic sideroblastic anemia, severe neutropenia 
or thrombocytopenia. The presence of vacuolization in granulous and 
erythroblastic progenitors, visible on the myelogram, is highly suggestive 
of the syndrome. Besides the hematological deficiency, patients present with 
fibrotic exocrine pancreatic dysfunction with malabsorption and diarrhea, 
or a defect in oxidative phosphorylation resulting in lactic acidemia and 
an increased lactate/pyruvate ratio. Other organs can be affected, either 
simultaneously or during the course of the disease: frequent renal involvement 
with tubulopathy and aminoaciduria is observed, as well as hepatic involvement 
with hepatomegaly, cytolysis and cholestasis, endocrine gland disturbances, 
neuromuscular disorders, cardiac involvement and splenic atrophy. 
Although maternal transmission has been described, it is typically sporadic 
mitochondrial cytopathy caused by mtDNA deletions. These deletions lead to 
a deficiency in mitochondrial respiratory chain function. The heteroplasmy, 
explains the high variability in clinical expression observed both between 
patients and between the various organs of an affected subject. Indeed, 
pathological manifestations occur when some level of mutated DNA has 
accumulated in a given tissue. 
Pearson’s syndrome is diagnosed by the presence of a single large scale 
rearrangement of mtDNA, as observed in Southern blot hybridization 
analysis of blood DNA. Management is symptomatic and includes treatment 
of infectious episodes and of metabolic accidents, transfusion in case of 
severe anemia (sometimes with erythropoietin therapy), pancreatic extracts 
and management of endocrine disorders. Death often occurs before the age 
of three years, due to septic risks, metabolic crisis with lactic acidosis or 
hepatocellular failure. Patients who survive early infancy typically undergo 
phenotypic evolution: hematological manifestations spontaneously resolve, 
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whereas neurological and myopathic signs either appear 
or worsen. Some patients develop typical kearns sayre 
syndrome with ophthalmoplegia, ataxia, pigmentary 
retinitis, conduction defects and myopathy.
Neuropathy, ataxia, and retinitis pigmentosa 
(NARP) 
NARP is characterized by developmental delay, 
seizures, proximal neurogenic muscle weakness, 
ataxia, dementia, sensory neuropathy, and retinitis 
pigmentosa. 
This is a maternally transmitted multisystem disorder 
of young adult life which is associated with a T8993G 
mutation (mutation resulting in the replacement of 
a leucine by arginine) in the ATPase 6 gene. The 
mutation is heteroplasmic, the clinical severity of the 
disease being dependent on the proportion of mutant 
mtDNA. A T8993C mutation (mutation resulting in 
the replacement of leucine by proline) and T9176C 
mutation alter the ATPase 6 gene were associated 
with a less severe clinical course of NARP. These 
mutations are invariably heteroplasmic and result in 
a broad range of clinical manifestations from mild 
peripheral retinitis pigmentosa to severe neurological 
disease, depending on the percentage of mutant 
mtDNAs. When the percentage of mutant mtDNA is 
>95%, patients show the clinical, neuroradiological 
and neuropathological findings of maternally inherited 
Leigh’s syndrome (MILS). MILS is a multisystem 
degenerative encephalopathy with onset in infancy, 
characterized by hypotonia, myoclonus, brainstem 
dysfunction, peripheral neuropathy, developmental 
delay, psychomotor regression, ataxia, seizures, and 
optic atrophy. NARP and MILS may co-exist in the 
same family. 
Brain MRI examination of NARP patients has 
revealed the presence of moderate, diffuse cerebral and 
cerebellar atrophy, and, in the most severely affected 
patients, symmetric lesions of the basal ganglia. In 
muscle biopsy, RRF are absent. Muscle fibers are COX 
positive, but a subset of fibers may be either negative or 
deficient for mitochondrial ATPase. The diagnosis can 
be confirmed by the characteristic pathological findings 
in brain MRI. In addition, retinitis pigmentosa, present 
in about half of MILS patients, is a distinguishing 
